Add BrightSurf on Google Email

Rodents could be asymptomatic carriers of SARS-like coronaviruses, study suggests

A study published in PLOS Computational Biology found that rodents have a greater diversity and accelerated rate of evolution in the ACE2 receptors used by SARS viruses. This suggests that some rodent species may be asymptomatic carriers of SARS-like coronaviruses, potentially leading to new pathogen transmission to humans.

SourcePLOS·JournalPLOS Computational Biology·TypeComputational simulation/modeling·DateNov 18, 2021

COVID-19: Does having received the BCG vaccine as a child provide a protective effect?

A Quebec research team conducted the first-ever study to examine the long-term protective effect of the BCG vaccine against COVID-19. Despite previous studies suggesting a correlation between childhood vaccination status and lower mortality rates, the researchers found no long-term protective effect of BCG against COVID-19.

SourceInstitut national de la recherche scientifique - INRS·JournalVaccine·TypeCase study·DateOct 25, 2021

COVID-19: Coughing without masks, distancing alone is not enough

Researchers from McGill University found that unmasked individuals can spread COVID-19 airborne particles up to 70% within a 2-meter radius, highlighting the need for mask-wearing and ventilation. The study suggests that current guidelines relying solely on physical distancing may not be sufficient to prevent transmission.

SourceMcGill University·JournalBuilding and Environment·TypeComputational simulation/modeling·DateOct 5, 2021

OSU study on African buffalo offers insights on persistence of highly contagious pathogens

A new OSU study on African buffalo offers insights into the persistence of highly contagious foot-and-mouth disease pathogens. Researchers found that carrier transmission among certain strains can allow them to persist in populations, highlighting the need for public health interventions to limit transmission and endemicity.

SourceOregon State University·JournalScience·TypeExperimental study·DateSep 30, 2021

AI may predict the next virus to jump from animals to humans

A study published in PLOS Biology suggests that machine learning models using viral genomes can predict the likelihood of an animal-infecting virus infecting humans. The researchers identified generalizable features in viral genomes that are independent of taxonomic relationships and developed models to identify candidate zoonoses.

SourcePLOS·JournalPLOS Biology·TypeComputational simulation/modeling·DateSep 28, 2021

Discovery of mechanics of drug targets for COVID-19

A team of international researchers has unraveled the inner workings of C5aR2, a key receptor involved in inflammation and COVID-19. The study provides an additional opportunity for therapeutic targeting with new drug molecules to block its activation and inflammation response.

SourceMcGill University·JournalMolecular Cell·TypeExperimental study·DateSep 27, 2021

Deadly virus’s pathway to infect cells identified

Researchers at WashU Medicine and University of Pittsburgh discover that Rift Valley fever virus uses a protein linked to cholesterol metabolism to infect cells. The finding could lead to therapies preventing or reducing the virus's impact by interfering with its entry into cells.

SourceWashU Medicine·JournalCell·TypeExperimental study·DateSep 23, 2021

Koala killer being passed to joeys from mum

Researchers at University of Queensland discover koala retrovirus is transmitted from mother to joey through close proximity, highlighting a significant threat to wild koala populations. This finding may lead to re-thinked conservation plans and the use of antiretroviral treatment to prevent transmission.

SourceUniversity of Queensland·JournalProceedings of the National Academy of Sciences·DateSep 6, 2021

Viruses leave traces for long after infection

Researchers have found that viruses like hepatitis B and C do not always kill infected cells, but instead cause long-term changes. These changes can affect genes related to cell division and metabolism, potentially contributing to increased risk of liver cancer in cured patients.

SourceUniversity of Basel·JournalJournal of Experimental Medicine·TypeExperimental study·DateAug 24, 2021

Reducing COVID-19 risk during dentist appointments

New research found that using electric drills instead of air-driven drills reduces aerosol spray by 99.98%, creating a safer environment for patients and dental teams. This could lead to a significant increase in treatments carried out, addressing the growing backlog of patients waiting for dental care.

SourceUniversity of Leeds·JournalJournal of Dental Research·DateAug 3, 2021

Combined effects of masking and distance on aerosol exposure potential

Researchers at Mayo Clinic found that wearing masks and maintaining physical distance significantly reduce the spread of COVID-19. The study showed that both disposable paper medical masks and two-layer cloth masks were effective in blocking aerosol particles, with increased distance reducing particle counts to near baseline levels.

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateJul 29, 2021

The virus trap

An interdisciplinary research team at TUM has developed nano-capsules tailored from genetic material using the DNA origami method to engulf and neutralize viruses. The strategy has been tested against hepatitis and adeno-associated viruses in cell cultures and may prove successful against corona viruses.

SourceTechnical University of Munich (TUM)·JournalNature Materials·DateJul 15, 2021

US conservatives less able than liberals to distinguish truth from falsehoods in study of responses to 240 political news stories

A study of over 1,000 Americans found that conservatives were more likely to believe false claims about politics that benefited the right, while liberals were more likely to believe true claims that favored the left. This suggests that the political environment and widely shared news plays a role in shaping conservative misperceptions.

Tackling tumors with two types of virus

A Swiss research group has developed a novel cancer vaccine strategy utilizing two different viruses to stimulate the immune system against tumor cells. In animal experiments, this approach led to the elimination or slowing down of tumors in 20-40% of cases.

SourceUniversity of Basel·JournalCell Reports Medicine·DateMar 3, 2021